Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

The Ultimate Place For Kids Opening Soon! – Ninja Nation


Ninja Nation, America’s leader in world-class obstacle course arenas, announces the opening of its fourth location in the U.S, its first franchise location and second location in the Dallas, Texas area. The Arena is set to open at the end of August or early September with multiple sneak peek mobile obstacle course events:

  • Warped Wall pop up event – Aug 1st – 9am – 2pm.
  • Official Sneak Peek Event – Aug 8th – 9am – 2pm.

We will have Ninja Nation Membership Specials, Ninja Nation Gear, Gift Cards and more for purchase on site for all events.

The 12,100 square foot facility at 150 Farm to Market Rd 544 E in Murphy will bring the professional and high energy Ninja Nation experience to life with state-of-the-art equipment, group classes, birthday parties, open gym, special events and competitions that will empower everyone to push their minds and bodies to the limits they never thought possible.

Texas based business owners; Bill & Mary Jane Journey are Ninja Nation’s first franchisees to open in the Texas Market. “Being a part of the Ninja Nation family is such a fun and rewarding experience for us!” said Bill Journey. “We love the opportunity to create a ninja facility in Murphy Texas and look forward to making a significant positive impact on kids and the whole community. There is nothing more fulfilling than seeing people come together as part of the ninja community and support each other as they learn to overcome the many fun and challenging obstacles on the course. Kids and adults also end up gaining the strength and confidence in themselves to overcome life’s obstacles along the way.”

Ninja Nation Founder and CEO, Wayne Cavanaugh, is thrilled to open the second location in Texas and our first Franchise location with Bill & Mary Jane Journey. “We have seen the sport of Ninja taking off in the Dallas/Fort Worth area and we are thrilled to have Bill & Mary Jane opening their Ninja Nation in Murphy. We are looking forward to being an integral member of this vibrant and dynamic community.”

Ninja Nation in Murphy, TX is thrilled to have Tyson Faifer, the first comedian to ever compete on NBC’s American Ninja Warrior, join the team as arena manager. Tyson has a passion for fitness and making people laugh and he now brings his leadership and passion of the sport of Ninja to Ninja Nation. “Ninja Nation is the ultimate place for family fun, I jumped at the chance to help bring this project to life!” said Tyson Faifer.

Exciting news for the fall 2020 school year! Introducing NINJA CARE!

Ninja Nation is offering a unique Ninja Care this Fall to accommodate a modified school experience. Starting the first week of school for each local district, Ninja Nation Murphy will have a limited number of spaces available for students to come to complete their distance/E-learning at Ninja Nation. Ninja Nation staff will support your child’s independent assigned learning but will not be responsible for teaching curriculum to students. In addition to providing a quiet, safe place for students to complete their assigned class curriculum, they will be provided an opportunity for physical activity on our world-class obstacle course!

Ninja Nation Services

Ninja Nation offers monthly memberships, organized group fitness classes, open gym, events, competitions, field trips, birthday parties and even a mobile unit for a Ninja obstacle courses anywhere. The inaugural Texas location opened in Frisco, TX in October 2018 and Ninja Nation has 2 additional Arenas in Colorado and 5 mobile Ninja obstacle courses throughout the United States.

About Ninja Nation

Ninja Nation is the leading provider of obstacle course arenas across the country, serving America’s youth and adults with the most exciting facilities for developing skills, strength, and confidence. We love the sport of Ninja and Obstacle Course Racing, support every aspect of its growth, and believe everyone across the U.S. should have access to such an incredible activity.

We believe in providing a fitness alternative that is fun, challenging and teaches us to get back up and try again. We are development focused, driven to help anyone who comes through our doors to get stronger, more fit, and more confident. Our goal is to create over one million heroes. That is one million kids and adults pushing their minds and bodies to limits they never thought possible in our arenas. Play, Train and Compete. Ninja Nation.

Follow us for the latest updates:

http://www.NinjaNation.com/nn0202

https://www.facebook.com/ninjanationmurphytx/

Contact Info

Tyson Faifer – NN0202.manager@ninjanation.com or 817-797-8622

Video Link – https://youtu.be/kBduKshlQm4

Share article on social media or email:

Luxx Lights the Path to Success for Cannabis Grows Around the Globe


“We’re just guys hustling on the street like our growers, and so we get it. From day one, everything we’ve done has been about the grower,” said General Manager Brent Nicholls.

Luxx Lighting, a grassroots company that provides high-performance lighting to cannabis cultivators, has expanded its global self-distribution model by adding warehouses in the US, Canada, Australia and the UK.

General Manager Brent Nicholls says that their choice to pursue self-distribution rather than working with a distributor sets Luxx apart in the industry. “We went down some distributor paths, but our growers reached out with feedback that let us know this old school model was not working,” he said. “It carried price and accessibility issues that didn’t align with our company vision or core business principles, which led us to take on the challenge of global self-distribution.

“Our goal has always been to support our retail partners – we know the industry was built on the back of hard-working mom and pop businesses and rather than line the distributor’s pockets, we bring the profits back to the store by cutting out the middleman.”

Luxx offers self-service, fully automated ordering and fulfillment, with orders shipping out within 24 hours of being received. This speedy turnaround is key, Nicholls said, as it can make or break a garden’s success.

Luxx’s most well-known product is the Luxx DE-1000, a double-ended light fixture that founder Brandon Burkhart says is the workhorse of the industry, consistently testing higher than any other light on the market. Burkhart, a cannabis industry veteran with over a decade of cultivation experience, worked with California cannabis company Jungle Boys to develop the light with the mindset that it takes a grower to understand what a grower needs.

“Jungle Boys tested the DE-1000 fixture multiple times, and after seeing how much their yield went up they ordered 2000 lights on the spot,” Burkhart said. “We operate in a yield game – light matters. The increases in yields our growers report can change the proformas of their business.”

Burkhart created Luxx Lighting with over 12 years of Hydroponics retail, manufacturing and product development, while Nicholls brought 13 years of international sales & finance acumen. The pair have teamed up to make a formidable force in the lighting segment of the cannabis industry.

“We are the first true grower founded, grower focused lighting company,” Nicholls said. “From day one, everything we’ve done has been about the grower. We’ve built Luxx organically – we’re just guys hustling on the street like our growers, and so we get it. We understand the challenges growers deal with on a daily basis, and we’re able to offer them a customer service experience that just isn’t possible when working with a distributor.”

Fully self-funded, Luxx saw a 400% increase in revenue in 2019 and a 150% increase so far in 2020. “The growth has been humbling – seeing the support from the global cultivation community is amazing,” Nicholls said. “The market tells you if you are doing the right things. Our goal moving forward is to continue investing our success in the company, supporting our growers and bringing the new phase of lighting technology – LEDs – to the market. It’s not just about selling LED’s, it’s about helping growers become successful with them.”

About Luxx Lighting:

“Designed in Los Angeles, Cultivated Worldwide.” Founded in 2018, Luxx Lighting provides industry-leading, high-performance cultivation lighting for cannabis grows. With an extensive background in cultivation, the Luxx team understands the challenges growers face and has developed unique products and an unparalleled customer service experience. They have put hundreds of thousands of lights into the market around the world and are a favorite with cannabis cultivations of all sizes including well-known brands such as Jungle Boys, GTI, The Originals, DTPG, Foreign Genetics and Green Leaf Medical.

Share article on social media or email:

inLighten Releases iVIEW Clean™ Digital Signage Stations with Integrated Hand Sanitizer Dispenser


Digital Signage Display Station with Hand Sanitizer

inLighten’s iVIEW Clean – Digital Signage Display Station with Hand Sanitizer

We started by designing a high quality product that combined a digital signage player and display with a touchless dispenser for hand sanitizer in a single unit.

inLighten® (http://www.inlighten.net), for more than 30 years a leader in the field of digital signage, interactive, and audio solutions today announced the release of iVIEW Clean Digital Signage Stations. Designed to make it easy to deploy essential visual messaging in virtually any location, when combined with a touchless hand sanitizer dispenser, iVIEW Clean generates greater awareness of essential information as well as increased compliance with health and safety measures.

In announcing the product’s release, inLighten CEO Dan Snyder described the considerations that were part of developing the iVIEW Clean solution. “First, we started by designing a high quality product that combined a digital signage player and display with a touchless dispenser for hand sanitizer in a single unit. We focused on making iVIEW Clean compact so that the need for wall and floor space would be minimal, allowing iVIEW Clean units to be located anywhere. We also knew that the product had to have the full complement of control and creation capabilities as our Apollo™ and iBOX™ digital signage systems, enabling our clients to add it to their pre-existing digital signage networks and manage it from the same platform. And, finally, we started thinking about enhancements such as temperature scanning and touchscreen capabilities that we’re offering as optional add-ons.”

Jeff Taylor, Vice President of Product Development shared some of the product specifications and pointed out additional features. “iVIEW Clean is outfitted with a 21.5 inch vertical display and integrated digital signage player. The enclosure, mounting bracket, stand and base are all made of steel – making the system really durable – and the enclosure locks for security. The wall-mounted unit is 42 inches tall, 14 wide and 8.5 inches deep and the floor-mounted unit stands 77.5 inches tall. The built-in dispenser for hand sanitizer has a 33 oz. capacity and you can use liquid, gel or foam types.”

Snyder added in conclusion, “For all kinds of organizations, iVIEW Clean is a win-win-win situation. iVIEW Clean gives them the ability to locate messaging and sanitizing where it’s most needed and most effective. Dynamic video messaging calls attention to the hand sanitizer dispenser, which encourages a best safety practice. And while people are sanitizing their hands, they engage with screen content to become more aware, alert and better informed.”

inLighten is a recognized leader in networked digital media solutions including digital signage products, self-service kiosks, on-hold and environment audio services, check-in and queueing systems and speech privacy solutions that empower clients to effectively and securely communicate with their intended audience to deliver an enhanced consumer experience. inLighten serves clients in financial services, higher education, healthcare, manufacturing, utility, governmental and not-for-profit sectors. inLighten headquarters and operations are located in Clarence, New York.

Share article on social media or email:

Estrella Ear, Nose and Throat in Arizona Featured as a 2020 Top Patient Rated Sun City West Otolaryngologist by Find Local Doctors


News Image

It feels extremely rewarding for our practice to be recognized by Find Local Doctors. Our goal is always to provide patients with compassionate, effective and personalized care, says Dr. Jonathan Wiggenhorn

Estrella Ear, Nose and Throat is located at 14506 West Granite Valley Drive, Suite 124, in Sun City West, AZ. Find Local Doctors has recently awarded this location the title of being a 2020 Top Patient Rated Sun City West Otolaryngologist. This practice has received a large number of five-star ratings and superior reviews from real patients. Find Local Doctors is a trusted online directory that helps consumers easily locate top-notch, reputable physicians in their area. This well-respected practice is among an exclusive group to receive a high volume of outstanding patient reviews. Estrella Ear, Nose and Throat in Sun City West, AZ, is committed to providing solutions to solve a wide range of conditions.

The physicians at this practice offer comprehensive allergy treatment for the entire family, advanced in-office sinus procedures, such as balloon sinuplasty, and a complete, full-service ear, nose and throat clinic. These ear, nose and throat experts perform thorough testing and treatment for problems such as allergies, chronic snoring, ear infections, cancer, sinusitis and hearing/balance problems for pediatric and adult patients. Minimally invasive procedures are able to be performed as an outpatient appointment at Estrella ENT. The doctors at this practice take the time to assess each patient and provide tailored treatment options. Their allergy treatments allow patients to avoid a hospital visit.

Estrella ENT specializes in helping patients get to the bottom of sinus issues. The team provides effective treatment solutions, including ClariFix for chronic rhinitis, Latera implants for nasal obstructions, sinus surgery/balloon sinuplasy and turbinate reduction surgery. They also offer Vivear nasal airway remodeling, using a recent technology that offers an alternative, minimally invasive option. These sinus procedures can be completed at Estrella ENT’s full-service clinic, offering the convenience of patients not having to go to the hospital during this time. The experts at Estrella ENT in Sun City West are passionate about providing an individualized approach and exceptional care to their patients, treating problems quickly and successfully.

“It feels extremely rewarding for our practice to be recognized by Find Local Doctors. Our goal is always to provide patients with compassionate, effective and personalized care,” says Dr. Jonathan Wiggenhorn

More about Estrella Ear, Nose and Throat:

At Estrella Ear, Nose and Throat, they value and appreciate each and every patient. The team prides itself on providing a superior, individualized care plan for patients and their family members of all ages. Estrella ENT operates two clinics in Arizona which are located in Sun City West and Goodyear. The two physicians leading the practice are Dr. Jonathan Wiggenhorn and Dr. Alan Brenner. They are both highly-regarded, board-certified physicians with extensive experience and top credentials in their field. All of the team members at Estrella Ear, Nose and Throat are dedicated to providing first-rate, excellent care for their patients. For more information about Estrella Ear, Nose and Throat’s Sun City West or Goodyear locations or to schedule an appointment, please visit http://www.estrellaent.com or call (623) 535-8770.

Share article on social media or email:

Zonar Delivers COVID-19 Driver and Passenger Resources and Solutions for a Safe Return Back to School


News Image

School bus drivers are tasked with being guardians of their pupil passengers to and from school. Providing safe transportation in the current COVID-19 world will require a fundamental change in the way drivers and officials comply with safety guideline

Zonar, the leader in smart fleet technology, today announced its COVID-19 Return to School Safety Solutions, a suite of dedicated compliance resources and configurable software solutions designed to establish new COVID-19 safety protocols for school bus drivers, students and fleet managers when schools return to in-person learning. Through these offerings, schools can more safely resume operations with readily available resources to adapt to rapidly changing requirements. Zonar’s COVID-19 Return to School Safety Solutions enable fleet managers and drivers to create more touchless experiences, address student tracking, ensure verified sanitization of buses, aid in contact tracing, with numerous options for funding.

School districts are experiencing unprecedented disruptions due to COVID-19. With some lockdown restrictions easing, decision-makers must address the urgency and complexity of reopening their schools. One of the biggest challenges will be to adjust working conditions and adopt new safety practices in order to reinforce parent, staff and driver confidence in school bus transportation. Providing a safer and technologically enhanced environment is a crucial step for these operations to return to normalcy. According to a panel of infectious disease experts at the University of California, San Francisco, up to 70 percent of the U.S. population could contract COVID-19 in the next 12 to 18 months. Taking every step to mitigate the risk of transmission as millions of students return to school is paramount.

“School bus drivers are tasked with being guardians of their pupil passengers to and from school. Providing safe transportation in the current COVID-19 world will require a fundamental change in the way drivers and officials comply with safety guidelines,” said H. Kevin Mest, senior vice president and general manager of passenger services at Zonar. “There is no one way to deal with the devastating effects of the pandemic on school transportation. Creating an environment that protects everyone will require discipline and access to customizable technologies like those Zonar developed to address a fleet’s changing requirements.”

Apart from sanitization measures, maintaining strict adherence to social distancing and mask-wearing policies will be important. Zonar’s COVID-19 Return to School Safety Solutions help schools meet the unique and varying needs of their student population as they return to classes as well as create meaningful changes, empowering families, drivers and teachers to feel safe and successful in the upcoming school year. The COVID-19 Return to School Safety Solutions combines Zonar’s expert support with pupil transportation offerings that utilize existing infrastructure, help reduce physical touchpoints, ensure sanitization of buses, aid in contact tracing – all while giving parents greater peace of mind.

The Zonar COVID-19 Return to School Safety Solutions includes tools that help:

Design your new normal with expert resources:

  • Zonar’s Safety & Compliance team comprised of industry veterans can help schools stay up-to-date with regulatory and national/state/local guidance, safety standards, regularly updated resources from the Center of Disease Control (CDC), free webinars and 1:1 advice for schools around compliance and regulations through an easy-to-use form. This is in addition to Zonar’s 24/7/365 customer success team, which is at the ready to handle any customer or product specific inquiries.

Find ways to fund your COVID-19 school transportation initiatives:

  • Budgets are limited. If you’re facing a shortfall for fleet management technology, ask our professionals about grant opportunities such as our Don Carnahan Memorial Grant and our partnership with Learn Design Apply, Inc. We can connect you with grant writing experts who offer professional assistance from research to project implementation.

Standardize and electronically verify cleaning protocols:

  • To help ensure buses are properly sanitized, Zonar’s patented Electronic Verified Inspection Reporting (EVIR®) solution has a new electronically verifiable configuration that helps school officials ensure the cleanliness and sanitization of buses according to CDC guidelines.

Support contact tracing with digital rider visibility:

  • Zonar provides Z Pass™ a contactless, card-based rider verification solution allowing schools to know who rode which bus and when so that—if a rider tests positive for COVID-19—you can quickly notify the driver and parents regarding the potential exposure.

Verify right student, right bus, right stop

  • With many schools going to a staggered schedule, Zonar Verify™ prevents students from getting on the wrong bus or off at the wrong stop. With assistance from the contactless, card-based Z Pass students scan entry and exit from the bus, Verify automatically confirms from the daily routing information that it’s the right student, right bus and right stop.

Keep parents and caregivers informed about their child’s bus location

  • Zonar MyView™ put parents and caregivers peace of mind right into the palm of their hand. Parents use the mobile app to locate their child’s bus, customize alerts and share and manage access with authorized caregivers. Plus, districts can utilize the back-end portal to communicate bus changes or COVID-related updates to the parent’s phone.

Update Cummins engines – no mechanic, no cost, no contact:

  • A trip to the shop for an engine update can take days and require an in-person hand-off. With Zonar OTAir™, fleet managers and maintenance workers can update their buses engine control units remotely and safely through their phone in as little as five minutes. Less downtime, less exposure. One less thing to worry about as you modify bus routes and schedules.

For more information about the Zonar COVID-19 Return to School Safety Solutions, find the resource page here: https://www.zonarsystems.com/packages/covid-19-student-transportation-solution/

About Zonar

Founded in 2001, Zonar has pioneered smart fleet management solutions throughout vocational, pupil, mass transit and commercial trucking industries. Zonar’s mission is to enhance the safety, performance and success of our customers by transforming the delivery of innovative insights for commercial fleets around the world. Zonar achieves this by helping fleets of all sizes maximize the use of their assets with solutions dedicated to improving compliance, efficiency, maintenance, ridership visibility, safety and tracking. Cloud-based services with open APIs drive Zonar’s smart fleet solutions by making it easy for fleet owners and managers to stay connected to their fleets and drivers and operators to dispatch. Headquartered in Seattle and part of the Continental family, Zonar also has a Technology Development Center in downtown Seattle, a regional office in Cincinnati, and a distribution center outside of Atlanta. For more information about Zonar, go to http://www.zonarsystems.com.

Share article on social media or email:

New Jersey residents want restrictions to remain in place to fight the spread of COVID-19


“There’s scant evidence in New Jersey that the public is looking for a speedy return to normal as long as a treatment or a vaccine remain out of reach,” said Krista Jenkins, director of the FDU Poll.

New Jersey residents are prepared to wait as long as necessary to fully reopen the state, rather than rush to a return to normalcy as the country continues to struggle with the coronavirus in the absence of a vaccine or treatment. Most favor mandatory mask-wearing and, while fewer are convinced than Americans nationwide, a significant majority say they are confident that a vaccine, when it emerges, will have been adequately tested for safety and efficacy.

These findings are from the latest statewide survey conducted on behalf of the Fairleigh Dickinson University School of Pharmacy and Health Sciences by the FDU Poll. The phone survey was fielded from June 18 through June 30, 2020, among a random sample of 809 New Jersey adults.

Returning to normal

Two thirds of New Jerseyans favor keeping restrictions in place until a vaccine or treatment is available. Significantly fewer (29%) want a return to normal despite the risks, with Republicans the sole demographic where a majority (53%) support a return to normal life over restrictions. Sizable majorities of Democrats, women and men, all age groups, Whites and non-Whites, and individuals from across the income and educational spectrum all support continued restrictions.

“There’s scant evidence in New Jersey that the public is looking for a speedy return to normal as long as a treatment or a vaccine remain out of reach. It looks like the heavy toll the virus took early on in the pandemic has left state residents leery of letting down their guard,” said Krista Jenkins, director of the FDU poll and a professor of politics and government at FDU.

Support for mandatory mask wearing is also uniformly embraced. Overall, three-quarters (77%) believe mask wearing in public places should be mandatory, while 20 percent think masks should be considered optional and a reflection of one’s personal freedom. Again, Republicans were least supportive of this measure by a wide margin. However, even within this group, a solid majority (60%) favor mandatory mask wearing, while 37 percent believe masks should be optional.

“Making masks mandatory continues to be a divisive issue among Democrats and Republicans. Results from the state of New Jersey are similar to results from a recent FDU nationwide survey. More Republicans than Democrats are against making masks mandatory and believe it should be a person’s personal choice to wear one. Despite this division, the vast majority of New Jerseyans accept the evidence that masks are effective for protecting against the virus and that it’s a good thing to require them,” says Elif Özdener-Poyraz, Assistant Professor of Pharmacy Practice at Fairleigh Dickinson University, School of Pharmacy & Health Sciences.

Vaccines and medical concerns

The ability to return to normal will largely depend on the availability of a COVID-19 vaccine. However, questions remain regarding whether Americans will trust the vaccine’s safety and efficacy, and therefore take the inoculation when it becomes available. New Jersey adults are, for the most part, confident that a hypothetical vaccine will be safe and effective, but are less convinced than the rest of the country. While a recent nationwide FDU poll found that almost three-quarters of Americans (72%) are confident to some degree in a vaccine, only two-thirds of Garden Staters agreed; 19 percent are very confident, and 47 percent are somewhat confident. Over a quarter (28%) of N.J. adults are not at all confident that the vaccine will be ready for widespread use.    

While most people understand that a vaccine is the surest way to get New Jersey, and the country, back up and running, and a majority will likely or definitely get vaccinated (66%), many people in the state are still resistant. Almost one-third (30%) of New Jerseyans say they probably or definitely will not get the vaccine when available.

“The speed with which vaccines are being developed may be contributing to the public’s weariness to accept a coronavirus vaccine when it becomes available. Although a vaccine is likely months if not longer away from being approved, public health campaigns targeting vaccine acceptance need to be developed now,” says Julie Kalabalik-Hoganson, Director and Associate Professor of Pharmacy Practice at Fairleigh Dickinson University School of Pharmacy and Health Sciences.

As health experts continue to warn about a likely resurgence of the virus when the cooler months of fall and winter settle in, Garden State residents are also being encouraged to get the flu vaccine in order to keep non-COVID illnesses to a minimum. A majority of New Jersey adults are already poised to do this, as 58 percent already are regular flu vaccine recipients. Additionally, 61% say that because of the coronavirus pandemic, they are even more likely than usual to get a flu vaccine this year.

The full impact the pandemic will have on the long-term health of Americans is not yet known; but many are worried about the effects. Two-thirds say they are very or somewhat concerned that their or someone they love’s health will suffer because of not getting or delaying medical treatment for non-COVID-19 related health conditions out of fear of contracting the disease. Concern in the Garden State is higher than what the FDU Poll has found nationally, as 58 percent of adults across the United States say they are very or somewhat concerned about untreated medical conditions.

In New Jersey, concern is especially high among people of color, as almost half (47%) of non-White respondents say they are very concerned, as compared with a third of White respondents (32%).

Methodology

The survey was conducted by the Fairleigh Dickinson University Poll on a random sample of 809 New Jersey adult, ages 18 and older, with live callers on both landlines and cellular phones between June 18 through June 30, 2020. Persons without a telephone could not be included in the random selection process. Respondents within a household are selected by asking randomly for the youngest adult currently available. The interview was conducted in English and included 263 adults reached on a landline phone and 546 adults reached on a cell phone, all acquired through random digit dialing.

In this poll, the simple sampling error for 809 New Jersey adults is +/-3.8 percentage points (including the design effect) at a 95 percent confidence interval. Thus, if 50 percent of New Jersey adults in this sample favor a particular position, we would be 95 percent sure that the true figure is between 46.2 and 53.8 percent (50 +/- 3.8) if all New Jersey adults had been interviewed, rather than just a sample.

The full analysis, along with the poll’s questions and tables and a detailed methodological statement, can be found on the FDU Poll website.

About Fairleigh Dickinson University Devoted to the preparation of world citizens, Fairleigh Dickinson University offers over 100 undergraduate and graduate degree programs, including doctoral programs in pharmacy, nursing practice, clinical psychology and school psychology; and an AACSB-accredited business school. Degree programs are offered on two New Jersey campuses and at two international campuses: Wroxton College, in Oxfordshire in England, and the Vancouver Campus, in British Columbia, Canada. For more information, visit FDU.edu.

About the FDU Poll

The FDU Poll is a university based survey research center that began in 2001. It has conducted over a hundred publicly released polls guided by a mission to provide high quality, scientifically sound, non-partisan measures of important issues facing New Jersey and the nation. To learn more visit us online

About FDU’s School of Pharmacy & Health Sciences

The Fairleigh Dickinson University School of Pharmacy & Health Sciences is one of only two degree-granting pharmacy schools in New Jersey, and is the first in the state to be associated with a private university. The School’s dynamic program of study integrates the very best practices in pharmacy education today. The school has also expanded its presence in the field of public health and health professions with the addition of health sciences programs such as Master of Public Health, Master of Social Work, Occupational Therapy and Physician Assistant.

Vidyo and Ignis Health Power Telehealth Metrics with Clinical Workflow Intelligence


Vidyo, Inc. (Enghouse Vidyo), a leader in embedded video telehealth solutions, announced today a partnership with Ignis Health, the leading provider of telehealth analytics and performance measurement. The partnership enables Vidyo to integrate the Ignis Health Telehealth Resource Program (TRP), the only comprehensive analytics platform for telehealth utilization, into its VidyoHealth solution for deep insights and metrics reporting.

“We are thrilled to offer Ignis Health TRP analytics with the VidyoHealth solution,” said Reuben Tozman, General Manager, Enghouse Vidyo. “At a time when U.S. health systems are rapidly adopting telehealth solutions to deliver patient care, it’s essential that healthcare executives understand their usage and simplify oversight and reporting. Our HIPAA-compliant VidyoHealth solution delivers laser-focused insights into these investments.”

“VidyoHealth is much more than just a video call,” said Tozman, who cited features such as integrated translation services and future AI to automate doctor’s notes. “The integration of Ignis Health’s TRP platform continues to broaden our offering.”

“As both Vidyo and Ignis Health continue to innovate to exceed the needs of health systems’ telehealth programs, this partnership is a natural progression for the healthcare industry,” said Najib Ben Brahim, Founder and Chief Executive Officer of Ignis Health. “Now more than ever, the importance of telehealth is going to transform our industry and the need for enhanced performance reporting on both clinical and operational data is a necessity for all providers. TRP is a turnkey, comprehensive analytics solution for telehealth utilization.

Ignis Health’s TRP augments telehealth metrics with clinical workflow intelligence, providing health system administrators with insights into consultations and the ability to closely track clinical effectiveness and quality of patient care.

VidyoHealth with TRP supports comprehensive reporting and dashboards for multiple data sources such as video, EMR clinical utilization and billing information; alerting capabilities for under or overutilized telehealth resources, and management of all key telehealth assets to ensure operational efficiency.

“Health systems are under intense financial pressure,” said Tozman. “Every investment needs to demonstrate a reasonable payback. The VidyoHealth solution with TRP supports the shift to new financial models, like per-visit pricing, and offers insights specifically suited for this economic environment.”

The addition of TRP enables healthcare systems using VidyoHealth to report on compliance. It also provides executives with tools to pull data from across their telehealth networks, including video and clinical utilization, into configurable dashboards with ready-to-use information that can be shared with others in the health system ecosystem.

“Telehealth is increasingly the way patient care is delivered now,” said Tozman. “Vidyo’s partnership with Ignis Health ensures VidyoHealth offers healthcare providers a powerful platform for expanded access, improved patient outcomes and sustainable cost savings.”

Prospective and existing VidyoHealth clients interested in learning more about how TRP can improve their telehealth solutions should contact info@vidyo.com

About Enghouse Vidyo

Vidyo is a subsidiary of Enghouse Systems Limited, a software and services company traded on the Toronto Stock Exchange (TSX:ENGH). Vidyo enriches people’s lives by embedding real-time video into digital communications in the moments that matter most. Millions of people around the world connect visually every day through Vidyo’s secure, scalable technology and cloud-based services. Its patented platform integrates with virtually any application environment, network, and device to deliver the highest quality experiences that strengthen teams, build trust, solidify relationships, and improve quality of life. Learn more at http://www.vidyo.com, read our blog, or follow us on Twitter at @vidyo, on LinkedIn, and on Facebook.

About Ignis Health

Ignis Health provides the framework for quality telehealth programs by enabling healthcare-specific project management and analytics solutions. Through streamlined and standardized workflows, Ignis Health enables quick and efficient service creation and completion to achieve project milestones when setting up telehealth programs. Our analytics solution measures the efficacy and ROI of existing telehealth programs by overlaying clinical intelligence on top of telehealth metrics. For more information, visit our website and follow us on LinkedIn. Ignis Health is the leading provider of telehealth implementation and performance measurement software to healthcare organizations committed to delivering accessible and affordable high-quality care using telehealth. Its cloud-based platforms are enabling healthcare providers to implement new telehealth services swiftly and improve existing services on a constant basis through operations data and ROI. Ignis Health envisions a future where telehealth is just health.

Share article on social media or email:

Domestic Gag Rule Reduces Birth Control Access for Over 45,000 Women Living in Rhode Island


“This federal rule exacerbates an already challenging contraceptive access landscape for women struggling to make ends meet,” CEO Gillian Sealy, Power to Decide

Data released by Power to Decide estimate that 45,290 Rhode Island women of reproductive age (13-44) in need of publicly funded contraception live in a county impacted by the Title X Family Planning Program “domestic gag rule.”

The domestic gag rule requires health providers receiving Title X funds to withhold information from patients about abortion services and care. In addition, health centers are required to cease providing abortion care with non-Title X funds at sites that offer Title X supported services, such as contraceptive care, breast and cervical cancer screening and STI testing. The rule requires that abortion services, no matter how they are funded, be performed at a separate physical site, which is impossible for many health centers.

“The implementation of the domestic gag rule could impact over 45,000 women in need in Rhode Island,” said Gillian Sealy, CEO, Power to Decide. “This federal rule exacerbates an already challenging contraceptive access landscape for women struggling to make ends meet. Even before the domestic gag rule went into effect, more than 64,000 low-income women in Rhode Island lived in contraceptive deserts, counties in which there is not reasonable access to the full range of contraceptive methods. As a result, these women face financial barriers related to transportation, child care and taking unpaid time from work; costs they incur just to get the contraception they need.”

Data from Power to Decide show that 64,190 women living at or below 250% of the poverty level in Rhode Island live in contraceptive deserts, counties in which there is not reasonable access to a health center offering the full range of contraceptive methods. Of the 64,190 women in need, 2,310 live in counties without a single health center that provides the full range of methods. Nationally, more than 19 million U.S. women of low income live in contraceptive deserts.

In this challenging landscape, Rhode Island is taking steps to partially alleviate the impact of damaging federal policies and proactively expanding access to contraception in various ways. Rhode Island has already expanded Medicaid to adults with low-income, which helps decrease the percentage of uninsured women, and by extension, give them contraceptive coverage they need to live healthy lives. Further, Rhode Island has enacted state policies that extend the supply of prescription contraceptives. In addition, the Rhode Island legislature is considering bills to allow pharmacists to prescribe contraception and to protect insurance coverage of the full range of contraceptive methods, both of which would help expand access for more women. More information about these policies can be found here.

Power to Decide is a private, non-partisan, non-profit organization that works to ensure all people—no matter who they are, where they live, or what their economic status might be—have the power to decide if, when, and under what circumstances to get pregnant and have a child. Please visit us at http://www.PowerToDecide.org or follow us on Facebook and Twitter.

Share article on social media or email:

mTelehealth Announces Positive Outcomes of Remote Patient Monitoring in Feasibility Study with Leading U.S. Medical Institution


mTelehealth

“Our partnership with mTelehealth was critical to the success of this project, and has set the stage for paradigm-changing research in the near future,” stated Saro Armenian, D.O., Department of Population Sciences, City of Hope.

Results demonstrate mTelehealth’s Remote Patient Monitoring interventions for Cardiovascular Disease survivors were highly effective and yielded positive health outcomes

mTelehealth, LLC, a premier provider of Remote Patient Monitoring solutions, today announced positive results from a telehealth feasibility study it conducted with City of Hope National Medical Center, the Beckman Research Institute of City of Hope, and other leading U.S. medical institutions, demonstrating the benefits of mTelehealth’s Remote Patient Monitoring (RPM) Telehealth Kit for Cardiovascular Disease (CVD) patients.

The study, “Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease,” confirmed that mTelehealth’s RPM Telehealth Kit is a feasible and highly acceptable platform to monitor modifiable risk factors in Hematopoietic Cell Transplantation survivors at risk for CVD.

Study participants received mTelehealth’s RPM Telehealth Kit, which includes Bluetooth-enabled devices such as a blood pressure monitor, weight scale, and pulse oximeter, and a 4G-enabled Gateway that allows data transfer from the devices to the cloud-based mTelehealth Patient Portal.

Preliminary study findings concluded that mTelehealth’s RPM Telehealth Kit facilitated the development of CVD interventions in large groups of survivors at a fraction of the cost and resources necessary to deliver preventive and long-term survivorship care. The study showed high levels of patient compliance and involvement, better blood pressure control, and improved health-seeking behaviors. Additionally, more than 85% of participants agreed that the study allowed them to be more active in managing their health and kept them motivated.

“The results of this study, conducted with some of the finest healthcare institutions in the world and offered to high-risk patients, confirm the fundamental value proposition of Remote Patient Monitoring for Cardiovascular Disease patients,” stated Marc Poulshock, President and CEO of mTelehealth. “The COVID-19 global pandemic, which is causing a shortage of hospital capacity and straining healthcare workers, underscores the critical need to empower patients and medical professionals to use telehealth, telemedicine, and RPM to manage and improve care without stepping foot in a hospital or doctor’s office.”

“Our partnership with mTelehealth was critical to the success of this project, and has set the stage for paradigm-changing research in the near future,” stated Saro Armenian, D.O., Department of Population Sciences, City of Hope. “During these unprecedented times, it is imperative that we continue to explore new approaches to quality healthcare delivery for our most vulnerable and at- risk patients.”

The study was conducted with Children’s Hospital Los Angeles, City of Hope National Medical Center, Perelman School of Medicine at the University of Pennsylvania, Seattle Children’s Hospital, and the Beckman Research Institute of City of Hope.

mTelehealth’s RPM telehealth solution is eligible for CMS reimbursement under Current Procedure Terminology (CPT) and Healthcare Common Procedure Coding System (HCPCS) codes including 99091, 99446, 99447, 99448, 99449, 99451, 99452, 99453, 99454, 99457, 99458, G2012, G2010, G0513, and G0514.

About mTelehealth

mTelehealth, LLC, founded in 2010 and based in Delray Beach, FL, is a premier provider of Remote Patient Monitoring (RPM), Telemedicine, Chronic Care Management (CCM), Virtual Exam, Video Visit, and related Telehealth solutions. Our Remote Health Monitoring System, Powered by aTouchAway™, provides a complete solution to remotely collect, store, and report timely and accurate health information anywhere. We connect patients with their families and care providers through our easy-to-use, affordable, remote health monitoring kit. For more information, visit our website: https://mtelehealth.com, Facebook, LinkedIn, and Twitter.

Share article on social media or email:



LabRoots to Host Immuno-Oncology & Cancer Biology Live Virtual Event, July 29, 2020, featuring Agilent Technologies


LabRoots to Host Immuno-Oncology & Cancer Biology Live Virtual Event, July 29, 2020, featuring Agilent Technologies

Agilent and the newest members of the Agilent family, BioTek Instruments and ACEA Biosciences, are bringing together world-leading cell analysis experts, immunologists and scientists at the Immuno-Oncology & Cancer Biology Live Virtual Event, July 29, 2020, to explore the latest innovations in cancer immuno-therapies and cancer biology.

Real-time, live cell analysis tools that accurately probe and interpret immune cell parameters are at the frontier of the immune-oncology therapies currently being developed. Similarly, 3D cell culture technologies, particularly those that form spheroid and organoid models, are pivotal in understanding how tumor cells develop and behave.

At this virtual conference, Agilent, BioTek and ACEA, will be showcasing several of these cell analysis innovations relevant to cancer biology, via product launches, software demos, and scientific posters. There will be the opportunity to live chat with product experts from all three companies.

Eleven expert speakers and many on-demand presentations will contribute to a full scientific program of presentations throughout the day. The line-up includes, Cancer Immunologist Ping-Chih Ho, PhD from the Lausanne, Switzerland branch of the Ludwig Institute for Cancer Research; Pediatric Hematologist-Oncologist Christopher DeRenzo, MD, from St. Jude Children’s Research Hospital, Houston, Texas; and Fabio Cerignoli, PhD, Senior Field Application Scientist at Agilent Technologies.

Todd Christian, Vice President of Agilent’s Cell Analysis Division extends a warm welcome to join us on July 29th and adds, “We hope you will find your time here to be informative, valuable, and enjoyable!”

Produced on LabRoots’ robust platform, this interactive environment with an exhibit hall, poster hall and an Education Center, allows attendees to connect seamlessly across all desktop and mobile devices. By joining this online event, viewers can earn Continuing Education credits during presentations.

For more information or to register for the event, click here.

For Research Use Only. Not for use in diagnostic procedures.

About LabRoots

LabRoots is the leading scientific social networking website, as well as a primary source for scientific trending news, premier educational virtual events/webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining Continuing Education Credits from a wide range of topics through their participation in the webinars and virtual events.

Share article on social media or email: